- NORTH AMERICA EDITIONAustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
Canadian licensed producer Aphria confirmed it will begin trading on the NYSE on Friday, and will have a new ticker symbol on the TSX to align with its new listing.
Shares of Canadian licensed producer (LP) Aphria (TSX:APH) rose on Tuesday (October 30) following the announcement of the official date of its New York Stock Exchange (NYSE) listing.
Stock of the cannabis company in Toronto jumped on Tuesday by 7.36 percent to C$13.71 as of 12:00 p.m. EST. The LP will officially begin trading on the NYSE on Friday (November 2).
Aphria will change its ticker symbol on the Toronto Stock Exchange (TSX) to align with its NYSE listing to “APHA.” Aphria had obtained official approval from exchange regulators last Wednesday (October 24).
Shares of Aphria have been on a downhill since the start of legalization in Canada, October 17, alongside the rest of the public cannabis sector. Since legalization, the company’s stock has decreased 34.18 percent in value.
Vic Neufeld, CEO of Aphria, said the company will join an “elite” peer group of companies raising capital through American investors.
“Listing on the NYSE provides Aphria with access to the largest equity market in the world, with increased exposure to a vast array of US institutional and retail investors,” he said in the statement.
Aphria confirmed it will voluntarily delist its shares from the OTCQB exchange, which had traded under the ticker symbol “APHQF.”
Investor takeaway
This move by Aphria follows in the footsteps of fellow cannabis LPs Canopy Growth (NYSE:CGC,TSX:WEED) and Aurora Cannabis (NYSE:ACB,TSX:ACB).
Obtaining a US listing has proven to increase to the value of a cannabis company and in bringing legitimacy to the rest of the market.
“American investors like to buy American securities listed on the [NYSE] or NASDAQ,” Charles Taerk, president and CEO of Faircourt Asset Management, previously told the Investing News Network.
He went on to explain even though these investors have noticed the growth of the cannabis space, they hadn’t participated in the sector due to this preference.
Don’t forget to follow us @INN_Cannabis for real-time news updates!
Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.